University of Arizona
University, FunderROROpenAlexWikidata
People
Melissa Marie Herbst-Kralovetz
Professor
Director, center for innovation in brai
Professor
Professor of physiology
Associate professor
Ying-Hui Chou
Associate professor
Assistant professor
Professor
Stephen Adamo
Assistant professor
Regents professor
Patricia Haynes
Professor
Thomas Nuno
Associate research professor
Associate professor
Professor and head
Professor, radiology & imaging sciences
Sarah Yeo
Research associate professor
Professor
Prof and head, dept. of immunobiology
Sources: reporter.nih.gov
Part of
Sources: wikidata.org
Founded
Founded
Jan 1, 1885
Sources: ror.org
Trials
Early phase 1, Not yet recruiting, 30 people, Jul 30, 2026
Phase 3, Recruiting, 218 people, Jul 17, 2026
Collaborator, Phase 4, Recruiting, 2,400 people, Jul 1, 2026
Early phase 1, Recruiting, 30 people, Jun 4, 2026
Early phase 1, Enrolling by invitation, 15 people, Feb 20, 2026
Phase 4, Recruiting, 200 people, Dec 12, 2025
Phase 1/2, Active, not recruiting, 100 people, Aug 1, 2025
Collaborator, Phase 1/2, Not yet recruiting, 20 people, May 28, 2025
Collaborator, Phase 2, Not yet recruiting, 65 people, Mar 14, 2025
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Phase 1/2, Recruiting, 30 people, Feb 7, 2025
Improving Mobility After Revascularization in Peripheral Artery Disease
Collaborator, Phase 3, Recruiting, 386 people, Nov 13, 2024
Early phase 1, Terminated, 3 people, Oct 28, 2024
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
Early phase 1, Recruiting, 200 people, Oct 16, 2024
Collaborator, Phase 2/3, Completed, 125 people, Sep 19, 2024
Community Partnership for Telehealth Solutions to Convey Information and Enhance Care
Active, not recruiting, 15,128 people, Aug 7, 2024
Collaborator, Phase 4, Recruiting, 120 people, Apr 26, 2024
Phase 1/2, Recruiting, 90 people, Feb 28, 2024
Diabetes Self-Management Plus Tai Chi Easy
Completed, 28 people, Dec 22, 2023
SUV PDL1/PD1 in Sun Damaged & Sun Protected Human Skin of Participants
Suspended, 46 people, Dec 20, 2023
Early phase 1, Status unknown, 44 people, Oct 31, 2023
Sources: clinicaltrials.gov
Grants and prizes
U54, 2/2 Partnership for Native American Cancer Prevention, U54CA143924, $1.6M, 2009–2029, Sep 17, 2026
U01, Transforming Alzheimer's Risk Factor Therapeutics into Precision Combination Therapies to Treat AD, U01AG095263, $2.7M, 2026–2031, Sep 10, 2026
R56, Developing small molecule therapeutics for TDP-43 associated neurodegenerative diseases, R56AG097418, $640K, 2026–2027, Sep 9, 2026
R35, Understanding and Exploiting Loss of Y in Cancer, R35CA294022, $924K, 2025–2032, Sep 8, 2026
UG1, University of Arizona Cancer Prevention Clinical Trials Network, UG1CA242596, $851K, 2019–2031, Sep 4, 2026
P01, Perimenopause in Brain Aging and Alzheimer's Disease, P01AG026572, $5.1M, 2006–2031, Sep 3, 2026
National Institute of Environmental Health Sciences
R01, PFAS Exposure, PFAS Mitigation, and ADRD Biomarkers and Cognition, R01ES039490, $763K, 2026–2031, Sep 3, 2026
R56, Plasticity Reserve in Alzheimer's Disease: Longitudinal Insights from Preclinical and Prodromal Stages., R56AG096875, $396K, 2026–2027, Sep 1, 2026
National Institute of Neurological Disorders and Stroke
RF1, Pathological relevance of TDP-43 interactions with translation machinery in neurodegeneration, RF1NS149974, $1.8M, 2026–2029, Aug 31, 2026
National Heart, Lung, and Blood Institute
R01, Duerme Mejor: Promoting Sleep Health at the US-Mexico Border, R01HL183250, $739K, 2026–2031, Aug 28, 2026
Role of p21 positive senescent cells in radiation-induced skeletal injury and repair (sub-award to UNIVERSITY OF ARIZONA), usaspending_subaward/ASST_NON_R01AG082681_075/ED44Y3W6P7B9, $40.9K, 2026, Aug 27, 2026
UG3, PNA5 For Treatment of Vascular Cognitive Impairment and Dementia (VCID) and Alzheimer's disease related dementias (ADRD): A Phase 1a Safety and Tolerability Study, UG3AG104642, $6.3M, 2026–2027, Aug 27, 2026
R00, Cognitive Science to Radiology: Using EEG and Eye-tracking to Determine Why, How, and When Novices and Radiologists Miss Signs of Breast Cancer in Multiple-abnormality Mammography and Tomosynthesis, R00CA267163, $249K, 2022–2027, Aug 26, 2026
National Heart, Lung, and Blood Institute
R01, Early Origins of Chronic Lung Disease: From Birth to Age 45 Years, R01HL132523, $1.8M, 2016–2030, Aug 21, 2026
National Heart, Lung, and Blood Institute
R01, Assessing Clinical Effectiveness and Implementation of Worksite Sleep Health Coaching in Firefighters, R01HL162799, $784K, 2023–2028, Aug 20, 2026
T32, Translational Research in Alzheimer's Disease and related Dementias (TRADD), T32AG082631, $301K, 2023–2028, Aug 18, 2026
National Center for Chronic Disease Prev and Health Promo
Community-Based Participatory Research to Enhance Vaccine Uptake Across the Lifespan through Innovative Points of Access and Altering Norms in Border and Rural Regions, U48DP006882, $390K, Aug 14, 2026
U01, PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: an FDA required Toxicology Study, U01AG082617, $1.9M, 2023–2027, Aug 13, 2026
National Heart, Lung, and Blood Institute
R01, Endothelial-Mediated Genetic Risk for Vascular Disease, R01HL180762, $779K, 2026–2030, Aug 12, 2026
R01, The contribution of declines in functional connectivity to cognitive aging, R01AG049722, $532K, 2016–2027, Aug 6, 2026
Sources: reporter.nih.gov, openalex.org
Grants and prizes awarded
University of California at Davis
Determinants of age-induced hearing loss and reversal strategies (sub-award to UNIVERSITY OF CALIFORNIA, DAVIS), usaspending_subaward/ASST_NON_P01AG051443_075/TX2DAGQPENZ5, $175K, 2025, Nov 14, 2025
University of Southern California
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial (sub-award to UNIVERSITY OF SOUTHERN CALIFORNIA), usaspending_subaward/ASST_NON_R01AG063826_075/G88KLJR3KYT5, $72.9K, 2025, Jul 22, 2025
Precision Aging Network: Closing the Gap Between Cognitive Healthspan andHuman Lifespan (sub-award to THE CURATORS OF THE UNIVERSITY OF MISSOURI), usaspending_subaward/ASST_NON_U19AG065169_075/J9CDGR596MN3, $47.9K, 2025, Jun 2, 2025
Assessing the long-term impacts of the COVID-19 pandemic on disparities in cancer screening and foll (sub-award to KAISER FOUNDATION HOSPITALS), usaspending_subaward/ASST_NON_R01CA265020_075/P1RTMASB37B5, $456K, 2025, May 20, 2025
Sources: openalex.org
Funded papers
Glycocalyx and Metabolomic Profiles After Trauma Across Age and Frailty Groups: A Pilot Study
Sep 24, 2026
Sep 10, 2026
Human Y chromosome pan-organ mapping reveals progressive mosaic loss from normal to cancer
Sep 8, 2026
Aug 11, 2026
Voice changes in aging birdsong: A longitudinal study in adult male zebra finches
Aug 10, 2026
Aug 9, 2026
Jul 14, 2026
Apr 14, 2026
Feb 28, 2026
Jan 22, 2026
NCT06644560, Jan 18, 2026
Refining Sleep-Disordered Breathing Annotations Across Multiple Public Sleep Study Datasets
Dec 22, 2025
Nov 17, 2025
Community Wealth Protects Cognitive Health for Older Adults
Oct 29, 2025
Proteolysis targeting chimeras as senolytics: An emerging senotherapy for combating aging
Oct 15, 2025
SCR_023355, Oct 12, 2025
Oct 9, 2025
Jul 31, 2025
May 21, 2025
Use of context in updating affective representations of words in older adults
Feb 22, 2025
Sources: api.crossref.org, openalex.org
Named in competing interests
Fees or honoraria, Grants or research support, Oct 21, 2026
Consulting or advice, Sep 14, 2026
Fees or honoraria, Grants or research support, Dec 18, 2025
Consulting or advice, Patents or royalties, Nov 11, 2025
Shares or equity, Patents or royalties, May 6, 2025
Decoding Precision Aging: The Intersection of Cognitive Decline, Frailty, and Hormonal Biomarkers
Shares or equity, Patents or royalties, May 5, 2025
Associations between AHA's Life's Essential 8 and cognition in midlife and older adults
Fees or honoraria, Grants or research support, Oct 23, 2024
Patents or royalties, Jul 27, 2024
Multidimensional Sleep Health Problems Across Middle and Older Adulthood Predict Early Mortality
Fees or honoraria, Grants or research support, Mar 1, 2024
Fees or honoraria, Grants or research support, Jun 26, 2023
Shares or equity, Patents or royalties, Aug 5, 2021
Shares or equity, Patents or royalties, Apr 1, 2021
Patents or royalties, Nov 2, 2020
Shares or equity, Patents or royalties, Apr 26, 2018
Shares or equity, Patents or royalties, Nov 25, 2017
Shares or equity, Patents or royalties, Mar 11, 2017
Shares or equity, Patents or royalties, Feb 24, 2017
Fees or honoraria, May 12, 2016
Sources: pubmed.ncbi.nlm.nih.gov
Papers
medRxiv, Nov 16, 2026
Frontiers in pharmacology, Nov 16, 2026
Beat-to-beat blood pressure variability and Alzheimers disease pathophysiology
medRxiv, Nov 12, 2026
Comprehensive healthspan assessments and influence of sex as a biological variable in aging rats
Aging, Nov 11, 2026
Journal of translational medicine, Nov 9, 2026
SGLT2 Inhibitor Use and Bioprosthetic Valve Re-Intervention in Patients with Diabetes
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
SGLT2 Inhibitors and Long-Term Outcomes in Takotsubo Cardiomyopathy: A Retrospective Cohort Study
AHA Scientific Sessions 2026 abstract, Nov 9, 2026
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
A signaling pathway controls heart-cell division in newborn mice
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
Journal of Alzheimer's disease : JAD, Nov 6, 2026
Bacterial compound promotes gut stem cell renewal in mice
Science advances, Nov 6, 2026
Diabetology & metabolic syndrome, Nov 5, 2026
Brain structure linked to disrupted sleep in older adults
Alzheimer's & dementia : the journal of the Alzheimer's Association, Nov 5, 2026
PsyArXiv, Nov 4, 2026
Older age linked to less repetitive negative thinking
PsyArXiv, Nov 4, 2026
Before Heart Failure Diagnosis, Adults Are Frail and Symptomatic
Journal of cardiac failure - intersections, Nov 4, 2026
Frontiers in immunology, Nov 3, 2026
Remodeling of α1-Acid Glycoprotein Glycoforms During Long-Term Calorie Restriction
medRxiv, Nov 2, 2026